Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.55−0.30 (-6.19%)
Close on Nov 16, 2026Market cap $36.69MP/E –Yield –
Cryo-Cell International revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cryo-Cell International's revenue for the twelve months ending Aug 31, 2026 was $31.13M, down 2.0% year over year. For fiscal 2025 it was $31.57M, down 1.3% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is $31.99M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $31.57M | -1.3% |
| FY2024 | Nov 30, 2024 | $31.99M | +2.0% |
| FY2023 | Nov 30, 2023 | $31.34M | +3.3% |
| FY2022 | Nov 30, 2022 | $30.34M | +5.0% |
| FY2021 | Nov 30, 2021 | $28.88M | -7.3% |
| FY2020 | Nov 30, 2020 | $31.15M | -2.1% |
| FY2019 | Nov 30, 2019 | $31.82M | +8.9% |
| FY2018 | Nov 30, 2018 | $29.22M | +15.1% |
| FY2017 | Nov 30, 2017 | $25.38M | +9.8% |
| FY2016 | Nov 30, 2016 | $23.13M | +9.7% |
| FY2015 | Nov 30, 2015 | $21.09M | +4.8% |
| FY2014 | Nov 30, 2014 | $20.13M | +6.0% |
| FY2013 | Nov 30, 2013 | $18.99M | +5.7% |
| FY2012 | Nov 30, 2012 | $17.97M | +0.3% |
| FY2011 | Nov 30, 2011 | $17.92M | +0.9% |
| FY2010 | Nov 30, 2010 | $17.76M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $7.82M | -0.0% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $7.78M | -1.9% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $7.68M | -3.6% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $7.84M | -2.3% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $7.83M | -3.0% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $7.93M | -1.4% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $7.97M | +1.5% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $8.02M | +1.9% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $8.07M | +2.5% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $8.04M | +3.5% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $7.85M | +0.4% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $7.88M | +1.5% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $7.87M | +2.5% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $7.77M | +1.8% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $7.82M | +7.8% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $7.76M | +6.1% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $7.68M | +2.4% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $7.63M | +5.9% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $7.26M | +5.8% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $7.32M | -3.0% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $7.50M | -7.5% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $7.21M | -8.5% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $6.86M | -10.0% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $7.54M | -5.4% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $8.11M | -1.3% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $7.87M | -3.1% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $7.62M | +1.7% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $7.97M | -7.3% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $8.22M | +4.5% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $8.13M | +24.6% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $7.50M | +20.3% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $8.59M | +32.7% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $7.87M | +14.1% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $6.53M | +4.6% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $6.23M | +7.8% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $6.47M | +10.3% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $6.90M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $6.24M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $5.78M | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $5.87M | – |
See a number that looks wrong?